Lv3
348 积分 2023-09-24 加入
Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing
9天前
已完结
Two Mechanisms One Molecule: Developing a 'Truly' Bifunctional Degrader Targeting Rpn13 and CRBN
22天前
已完结
Regioselective Protection at N-2 and Derivatization at C-3 of Indazoles
1个月前
已完结
Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation
1个月前
已完结
RIMTAC: A Novel Degrader Design Platform by Indirect VHL-Recruitment via RIPK1
1个月前
已完结
HRS-5965, a small-molecule factor B inhibitor, in healthy participants and participants with renal insufficiency: A first-in-human, phase 1 trial
1个月前
已完结
From discovery to approval: A brief history of the compstatin family of complement C3 inhibitors
1个月前
已完结
Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention
1个月前
已完结
Compstatins: the dawn of clinical C3-targeted complement inhibition
1个月前
已完结
Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like Cells
1个月前
已完结
皖公网安备34019202002308
